Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine QLB-LSAL for post-cesarean analgesia
ChiCTR2600122673Phase 4Not yet recruiting
- Sponsor
- Ningde Mindong Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Ningde Mindong Hospital. Primary endpoint: Area under the curve of cumulative morphine consumption during first 72 hours postoperatively. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600122673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122673.